YAP1 and nonpapillary renal cell carcinoma: In that study we showed that YAP1 gene upregulation and worse clinical outcome of ccRCC patients as well as higher YAP1 protein expression in cancer tissue homogenates were associated with the clinical stage and pathomorphological features such as higher TNM and Fuhrman's stages [13].